Research & Academia

HDFCCC Molecular Oncology Program "Bridging the Gap" Seminar Series

Monday, January 05 at 12:00 pm - 1:00 pm Add to Calendar 2026-01-05 12:00:00 2026-01-05 13:00:00 HDFCCC Molecular Oncology Program "Bridging the Gap" Seminar Series The Molecular Oncology Program (MOP) at the UCSF Helen Diller Family Comprehensive Cancer Center is dedicated to discovering and developing new preventive and therapeutic strategies, as well as identifying biomarkers, through research that spans basic science, clinical applications, and technological advancements. Our focus is on bridging the gap between scientists and clinical researchers and the translation of research into real-world medical applications. Presentations: Jason Sello, PhD, Vice Dean and Professor of Pharmaceutical Chemistry, UCSF Talk Title: Chemistry in Service of Medicine-New Pathways Towards Therapeutics for Cancer Mark Moasser, MD, Professor of Medicine, Div. of Hematology & Oncology, UCSF Talk Title: Insights into HER2-HER3 signaling ----- This is a meeting of the Molecular Oncology Program of the Helen Diller Family Comprehensive Cancer Center. For questions, please contact Meredith Donnelly ([email protected]). Helen Diller Family Comprehensive Cancer Center [email protected] America/Los_Angeles public

The Molecular Oncology Program (MOP) at the UCSF Helen Diller Family Comprehensive Cancer Center is dedicated to discovering and developing new preventive and therapeutic strategies, as well as identifying biomarkers, through research that spans basic science, clinical applications, and technological advancements. Our focus is on bridging the gap between scientists and clinical researchers and the translation of research into real-world medical applications.

Presentations:

Jason Sello, PhD, Vice Dean and Professor of Pharmaceutical Chemistry, UCSF

Talk Title: Chemistry in Service of Medicine-New Pathways Towards Therapeutics for Cancer

Mark Moasser, MD, Professor of Medicine, Div. of Hematology & Oncology, UCSF

Talk Title: Insights into HER2-HER3 signaling

-----

This is a meeting of the Molecular Oncology Program of the Helen Diller Family Comprehensive Cancer Center. For questions, please contact Meredith Donnelly ([email protected]).

Programmatic